67 related articles for article (PubMed ID: 27604679)
1. Humanized mouse as an appropriate model for accelerated global HIV research and vaccine development: current trend.
Ibeh BO; Furuta Y; Habu JB; Ogbadu L
Immunopharmacol Immunotoxicol; 2016 Dec; 38(6):395-407. PubMed ID: 27604679
[TBL] [Abstract][Full Text] [Related]
2. Current advances in humanized mouse models.
Ito R; Takahashi T; Katano I; Ito M
Cell Mol Immunol; 2012 May; 9(3):208-14. PubMed ID: 22327211
[TBL] [Abstract][Full Text] [Related]
3. Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.
Rozemuller H; Knaän-Shanzer S; Hagenbeek A; van Bloois L; Storm G; Martens AC
Exp Hematol; 2004 Nov; 32(11):1118-25. PubMed ID: 15539091
[TBL] [Abstract][Full Text] [Related]
4. Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution.
Abele-Ohl S; Leis M; Mahmoudian S; Weyand M; Stamminger T; Ensminger SM
Transpl Immunol; 2010 May; 23(1-2):59-64. PubMed ID: 20394817
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Antibody Responses in a Novel NOG Transgenic Mouse with Restored Lymph Node Organogenesis.
Takahashi T; Katano I; Ito R; Goto M; Abe H; Mizuno S; Kawai K; Sugiyama F; Ito M
Front Immunol; 2017; 8():2017. PubMed ID: 29387068
[TBL] [Abstract][Full Text] [Related]
6. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
7. A new immunodeficient mouse model for human myoblast transplantation.
Cooper RN; Irintchev A; Di Santo JP; Zweyer M; Morgan JE; Partridge TA; Butler-Browne GS; Mouly V; Wernig A
Hum Gene Ther; 2001 May; 12(7):823-31. PubMed ID: 11339898
[TBL] [Abstract][Full Text] [Related]
8. Human T cell development in the liver of humanized NOD/SCID/IL-2Rγ(null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells.
Choi B; Chun E; Kim M; Kim SY; Kim ST; Yoon K; Lee KY; Kim SJ
Clin Immunol; 2011 Jun; 139(3):321-35. PubMed ID: 21429805
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1.
Sato K; Nie C; Misawa N; Tanaka Y; Ito M; Koyanagi Y
Vaccine; 2010 May; 28 Suppl 2():B32-7. PubMed ID: 20510741
[TBL] [Abstract][Full Text] [Related]
10. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
[TBL] [Abstract][Full Text] [Related]
11. Characterization of HIV-1 infection in the humanized Rag2-/-γc-/- mouse model.
Sanchez FM; Berges BK
Methods Mol Biol; 2013; 1031():215-22. PubMed ID: 23824904
[TBL] [Abstract][Full Text] [Related]
12. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
[TBL] [Abstract][Full Text] [Related]
13. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
14. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
15. Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma.
Wang G; Ishikawa H; Sone K; Kobayashi T; Kim JJ; Kurita T; Shozu M
Fertil Steril; 2014 May; 101(5):1485-92. PubMed ID: 24636398
[TBL] [Abstract][Full Text] [Related]
16. A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.
Mazurier F; Fontanellas A; Salesse S; Taine L; Landriau S; Moreau-Gaudry F; Reiffers J; Peault B; Di Santo JP; de Verneuil H
J Interferon Cytokine Res; 1999 May; 19(5):533-41. PubMed ID: 10386866
[TBL] [Abstract][Full Text] [Related]
17. Improved B cell development in humanized NOD
Jangalwe S; Shultz LD; Mathew A; Brehm MA
Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
[TBL] [Abstract][Full Text] [Related]
18. Visualization of the human CD4⁺ T-cell response in humanized HLA-DR4-expressing NOD/Shi-scid/γc(null) (NOG) mice by retrogenic expression of the human TCR gene.
Takahashi T; Katano I; Ito R; Ito M
Biochem Biophys Res Commun; 2015 Jan; 456(1):219-24. PubMed ID: 25462565
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of human spleen into immunodeficient NOD/SCID IL2Rγ(null) mice generates humanized mice that improve functional B cell development.
Chung YS; Son JK; Choi B; Park JB; Chang J; Kim SJ
Clin Immunol; 2015 Dec; 161(2):308-15. PubMed ID: 26360254
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
